Global Non-invasive Vagus Nerve Stimulator Market Growth 2026-2032
The global Non-invasive Vagus Nerve Stimulator market size is predicted to grow from US$ 31.33 million in 2025 to US$ 79.45 million in 2032; it is expected to grow at a CAGR of 13.0% from 2026 to 2032.
Non-invasive Vagus Nerve Stimulator refers to a class of non-implantable neuromodulation medical devices that regulate vagus nerve activity through external electrical stimulation applied to the body surface. The products mainly include transcutaneous cervical vagus nerve stimulation (tcVNS) devices and transcutaneous auricular vagus nerve stimulation (taVNS) devices, typically consisting of a stimulation unit, electrodes, control module and supporting software. By adjusting stimulation intensity, frequency, pulse width and treatment programs, these devices modulate autonomic nervous system activity and neural pathways. The market primarily covers commercially available medical and home-use devices applied in neurological disorders, pain management, mental health support, sleep regulation and autonomic function modulation.
Key FindingsThe global average selling price of non-invasive vagus nerve stimulators was approximately US$700–1,200 per unit in 2025.The industry gross margin was approximately 35%–50%.Portable handheld devices remained the dominant product form.Wearable and connected devices became an important product upgrade direction.North America and Europe remained the major global regions for technology development and commercialization.Transcutaneous cervical vagus nerve stimulation and transcutaneous auricular vagus nerve stimulation remained the two major technology routes.Neurological disorders remained the most commercially mature application area.
Market Trends
The non-invasive vagus nerve stimulation industry is transitioning from research-oriented development toward broader clinical adoption and home healthcare applications. Product development is increasingly focused on improving stimulation precision, portability, treatment personalization and digital connectivity. Wearable stimulation systems integrated with mobile applications and remote monitoring functions are becoming important development directions.
Clinical application expansion remains a major industry trend. Existing commercial applications are mainly concentrated in neurological disorders, while depression, anxiety, sleep disorders, inflammatory regulation and autonomic function modulation continue to represent potential growth areas. The future expansion of the market will depend on clinical validation, treatment effectiveness and broader healthcare acceptance.
Market Dynamics
Drivers
The increasing demand for non-surgical alternatives to implantable neuromodulation devices is a major growth driver. Compared with implanted VNS systems, non-invasive devices reduce surgical risks, improve patient acceptance and support long-term home-based treatment. Growing demand for chronic disease management and personalized healthcare solutions further supports market development.
The integration of digital healthcare technologies is also accelerating product innovation. Devices with connectivity, treatment data tracking and personalized stimulation management capabilities are expected to enhance long-term patient management and create additional value beyond traditional hardware.
Restraints
The market remains constrained by differences in clinical evidence maturity among applications. While headache-related applications have achieved stronger commercialization progress, other indications remain under clinical evaluation. Regulatory differences and limited reimbursement coverage across regions may also slow market penetration.
Compared with implantable VNS systems, non-invasive devices generally provide lower stimulation intensity, which may limit adoption in certain severe neurological applications.
Opportunities
Expansion of home healthcare represents a major opportunity for non-invasive vagus nerve stimulation devices. Increasing demand for convenient and continuous treatment solutions is expected to support wider adoption of portable stimulation systems.
Mental health management, sleep improvement and autonomic regulation represent additional growth opportunities. Integration with wearable devices, artificial intelligence-based treatment optimization and digital therapeutics may further expand future applications.
Challenges
The industry faces challenges related to clinical validation, reimbursement adoption and technology differentiation. Establishing standardized treatment protocols and demonstrating long-term therapeutic benefits remain important for broader medical acceptance. Competition from other neuromodulation technologies may also influence future market positioning.
Industry Chain Analysis
The industry chain includes upstream electronic components, electrodes, semiconductor components and medical-grade materials; midstream device manufacturers responsible for stimulation hardware, software control and regulatory compliance; and downstream healthcare providers, research institutions and home users. Value creation is mainly concentrated in stimulation technology, clinical validation, regulatory approval and specialized healthcare channels.
Value Chain Analysis
Upstream suppliers provide electronic components, batteries, electrodes and supporting materials. Midstream manufacturers create differentiation through stimulation waveform design, device integration, software algorithms and clinical product development. Downstream value realization depends on physician adoption, reimbursement mechanisms, patient acceptance and long-term treatment adherence.
Segment Insights
By technology route, tcVNS and taVNS represent the two major market segments. tcVNS currently contributes greater commercial value due to stronger clinical commercialization, while taVNS maintains growth potential through research adoption and application expansion.
By product form, portable handheld devices represent the largest segment, supported by home healthcare demand and patient accessibility. Wearable and connected devices are expected to achieve faster growth as digital healthcare integration increases.
By application, neurological disorders remain the largest established application area, while mental health and sleep-related applications represent emerging growth opportunities.
Downstream Market Opportunities
Hospitals and clinics remain important purchasing channels for medical-grade systems, particularly in neurological and rehabilitation applications. Home healthcare represents a rapidly expanding downstream opportunity as patients seek convenient and continuous treatment solutions. Research institutions continue to support technology validation and indication expansion.
Regional Insights
North America represents the leading commercial market due to earlier regulatory development, established neuromodulation adoption and stronger healthcare infrastructure. Europe maintains technological advantages in auricular stimulation research and medical device innovation. Asia Pacific represents a high-potential growth region supported by increasing healthcare investment, neurological disease management demand and expanding local medical device capabilities.
Competitive Landscape Analysis
The competitive landscape is mainly concentrated in North America and Europe. Companies in these regions benefit from earlier regulatory experience, accumulated clinical evidence and specialized neuromodulation capabilities. North America focuses more on clinically validated therapeutic applications, while Europe maintains strong activity in auricular stimulation and research-oriented applications. Asia Pacific remains an emerging competitive region, with local companies gradually increasing participation through product localization and regional healthcare demand.
Report Scope
LP Information, Inc. (LPI) ' newest research report, the “Non-invasive Vagus Nerve Stimulator Industry Forecast” looks at past sales and reviews total world Non-invasive Vagus Nerve Stimulator sales in 2025, providing a comprehensive analysis by region and market sector of projected Non-invasive Vagus Nerve Stimulator sales for 2026 through 2032. With Non-invasive Vagus Nerve Stimulator sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Non-invasive Vagus Nerve Stimulator industry.
This Insight Report provides a comprehensive analysis of the global Non-invasive Vagus Nerve Stimulator landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Non-invasive Vagus Nerve Stimulator portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Non-invasive Vagus Nerve Stimulator market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Non-invasive Vagus Nerve Stimulator and breaks down the forecast by Technology Route, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Non-invasive Vagus Nerve Stimulator.
This report presents a comprehensive overview, market shares, and growth opportunities of Non-invasive Vagus Nerve Stimulator market by product type, application, key manufacturers and key regions and countries.
Market Segmentation
Non-invasive Vagus Nerve Stimulator refers to a class of non-implantable neuromodulation medical devices that regulate vagus nerve activity through external electrical stimulation applied to the body surface. The products mainly include transcutaneous cervical vagus nerve stimulation (tcVNS) devices and transcutaneous auricular vagus nerve stimulation (taVNS) devices, typically consisting of a stimulation unit, electrodes, control module and supporting software. By adjusting stimulation intensity, frequency, pulse width and treatment programs, these devices modulate autonomic nervous system activity and neural pathways. The market primarily covers commercially available medical and home-use devices applied in neurological disorders, pain management, mental health support, sleep regulation and autonomic function modulation.
Key FindingsThe global average selling price of non-invasive vagus nerve stimulators was approximately US$700–1,200 per unit in 2025.The industry gross margin was approximately 35%–50%.Portable handheld devices remained the dominant product form.Wearable and connected devices became an important product upgrade direction.North America and Europe remained the major global regions for technology development and commercialization.Transcutaneous cervical vagus nerve stimulation and transcutaneous auricular vagus nerve stimulation remained the two major technology routes.Neurological disorders remained the most commercially mature application area.
Market Trends
The non-invasive vagus nerve stimulation industry is transitioning from research-oriented development toward broader clinical adoption and home healthcare applications. Product development is increasingly focused on improving stimulation precision, portability, treatment personalization and digital connectivity. Wearable stimulation systems integrated with mobile applications and remote monitoring functions are becoming important development directions.
Clinical application expansion remains a major industry trend. Existing commercial applications are mainly concentrated in neurological disorders, while depression, anxiety, sleep disorders, inflammatory regulation and autonomic function modulation continue to represent potential growth areas. The future expansion of the market will depend on clinical validation, treatment effectiveness and broader healthcare acceptance.
Market Dynamics
Drivers
The increasing demand for non-surgical alternatives to implantable neuromodulation devices is a major growth driver. Compared with implanted VNS systems, non-invasive devices reduce surgical risks, improve patient acceptance and support long-term home-based treatment. Growing demand for chronic disease management and personalized healthcare solutions further supports market development.
The integration of digital healthcare technologies is also accelerating product innovation. Devices with connectivity, treatment data tracking and personalized stimulation management capabilities are expected to enhance long-term patient management and create additional value beyond traditional hardware.
Restraints
The market remains constrained by differences in clinical evidence maturity among applications. While headache-related applications have achieved stronger commercialization progress, other indications remain under clinical evaluation. Regulatory differences and limited reimbursement coverage across regions may also slow market penetration.
Compared with implantable VNS systems, non-invasive devices generally provide lower stimulation intensity, which may limit adoption in certain severe neurological applications.
Opportunities
Expansion of home healthcare represents a major opportunity for non-invasive vagus nerve stimulation devices. Increasing demand for convenient and continuous treatment solutions is expected to support wider adoption of portable stimulation systems.
Mental health management, sleep improvement and autonomic regulation represent additional growth opportunities. Integration with wearable devices, artificial intelligence-based treatment optimization and digital therapeutics may further expand future applications.
Challenges
The industry faces challenges related to clinical validation, reimbursement adoption and technology differentiation. Establishing standardized treatment protocols and demonstrating long-term therapeutic benefits remain important for broader medical acceptance. Competition from other neuromodulation technologies may also influence future market positioning.
Industry Chain Analysis
The industry chain includes upstream electronic components, electrodes, semiconductor components and medical-grade materials; midstream device manufacturers responsible for stimulation hardware, software control and regulatory compliance; and downstream healthcare providers, research institutions and home users. Value creation is mainly concentrated in stimulation technology, clinical validation, regulatory approval and specialized healthcare channels.
Value Chain Analysis
Upstream suppliers provide electronic components, batteries, electrodes and supporting materials. Midstream manufacturers create differentiation through stimulation waveform design, device integration, software algorithms and clinical product development. Downstream value realization depends on physician adoption, reimbursement mechanisms, patient acceptance and long-term treatment adherence.
Segment Insights
By technology route, tcVNS and taVNS represent the two major market segments. tcVNS currently contributes greater commercial value due to stronger clinical commercialization, while taVNS maintains growth potential through research adoption and application expansion.
By product form, portable handheld devices represent the largest segment, supported by home healthcare demand and patient accessibility. Wearable and connected devices are expected to achieve faster growth as digital healthcare integration increases.
By application, neurological disorders remain the largest established application area, while mental health and sleep-related applications represent emerging growth opportunities.
Downstream Market Opportunities
Hospitals and clinics remain important purchasing channels for medical-grade systems, particularly in neurological and rehabilitation applications. Home healthcare represents a rapidly expanding downstream opportunity as patients seek convenient and continuous treatment solutions. Research institutions continue to support technology validation and indication expansion.
Regional Insights
North America represents the leading commercial market due to earlier regulatory development, established neuromodulation adoption and stronger healthcare infrastructure. Europe maintains technological advantages in auricular stimulation research and medical device innovation. Asia Pacific represents a high-potential growth region supported by increasing healthcare investment, neurological disease management demand and expanding local medical device capabilities.
Competitive Landscape Analysis
The competitive landscape is mainly concentrated in North America and Europe. Companies in these regions benefit from earlier regulatory experience, accumulated clinical evidence and specialized neuromodulation capabilities. North America focuses more on clinically validated therapeutic applications, while Europe maintains strong activity in auricular stimulation and research-oriented applications. Asia Pacific remains an emerging competitive region, with local companies gradually increasing participation through product localization and regional healthcare demand.
Report Scope
LP Information, Inc. (LPI) ' newest research report, the “Non-invasive Vagus Nerve Stimulator Industry Forecast” looks at past sales and reviews total world Non-invasive Vagus Nerve Stimulator sales in 2025, providing a comprehensive analysis by region and market sector of projected Non-invasive Vagus Nerve Stimulator sales for 2026 through 2032. With Non-invasive Vagus Nerve Stimulator sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Non-invasive Vagus Nerve Stimulator industry.
This Insight Report provides a comprehensive analysis of the global Non-invasive Vagus Nerve Stimulator landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Non-invasive Vagus Nerve Stimulator portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Non-invasive Vagus Nerve Stimulator market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Non-invasive Vagus Nerve Stimulator and breaks down the forecast by Technology Route, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Non-invasive Vagus Nerve Stimulator.
This report presents a comprehensive overview, market shares, and growth opportunities of Non-invasive Vagus Nerve Stimulator market by product type, application, key manufacturers and key regions and countries.
Market Segmentation
Segmentation by Technology Route:
- Transcutaneous Cervical Vagus Nerve Stimulation (tcVNS)
- Transcutaneous Auricular Vagus Nerve Stimulation (taVNS)
- Others
Segmentation by Product Form:
- Portable Handheld Devices
- Wearable Devices
- Others
Segmentation by Application:
- Neurological Disorders
- Mental Health Disorders
- Pain Management
- Sleep Disorders
- Inflammation and Autonomic Regulation
- Others
This report also splits the market by region:
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- electroCore, Inc.
- Parasym Ltd.
- tVNS Technologies GmbH
- NEMOS GmbH
- NeuroSigma, Inc.
- Jiangsu Yuyue Medical Equipment & Supply Co., Ltd.
- Jiangxi Xinzhile Medical Technology Co., Ltd.
- Hangzhou Yijian Technology Co., Ltd.
- Hangzhou Raloway Technology Co., Ltd.
- NEURIVE Co., Ltd.
Key Questions Addressed in this Report
- What is the 10-year outlook for the global Non-invasive Vagus Nerve Stimulator market?
- What factors are driving Non-invasive Vagus Nerve Stimulator market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do Non-invasive Vagus Nerve Stimulator market opportunities vary by end market size?
- How does Non-invasive Vagus Nerve Stimulator break out by Technology Route, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Non-invasive Vagus Nerve Stimulator Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Non-invasive Vagus Nerve Stimulator by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Non-invasive Vagus Nerve Stimulator by Country/Region, 2021, 2025 & 2032
2.2 Non-invasive Vagus Nerve Stimulator Segment by Technology Route
2.2.1 Transcutaneous Cervical Vagus Nerve Stimulation (tcVNS)
2.2.2 Transcutaneous Auricular Vagus Nerve Stimulation (taVNS)
2.2.3 Others
2.2.4 Non-invasive Vagus Nerve Stimulator Sales by Technology Route
2.2.4.1 Global Non-invasive Vagus Nerve Stimulator Sales Market Share by Technology Route (2021-2026)
2.2.4.2 Global Non-invasive Vagus Nerve Stimulator Revenue and Market Share by Technology Route (2021-2026)
2.2.4.3 Global Non-invasive Vagus Nerve Stimulator Sale Price by Technology Route (2021-2026)
2.3 Non-invasive Vagus Nerve Stimulator Segment by Product Form
2.3.1 Portable Handheld Devices
2.3.2 Wearable Devices
2.3.3 Others
2.3.4 Non-invasive Vagus Nerve Stimulator Sales by Product Form
2.3.4.1 Global Non-invasive Vagus Nerve Stimulator Sales Market Share by Product Form (2021-2026)
2.3.4.2 Global Non-invasive Vagus Nerve Stimulator Revenue and Market Share by Product Form (2021-2026)
2.3.4.3 Global Non-invasive Vagus Nerve Stimulator Sale Price by Product Form (2021-2026)
2.4 Non-invasive Vagus Nerve Stimulator Segment by Application
2.4.1 Neurological Disorders
2.4.2 Mental Health Disorders
2.4.3 Pain Management
2.4.4 Sleep Disorders
2.4.5 Inflammation and Autonomic Regulation
2.4.6 Others
2.4.7 Non-invasive Vagus Nerve Stimulator Sales by Application
2.4.7.1 Global Non-invasive Vagus Nerve Stimulator Sale Market Share by Application (2021-2026)
2.4.7.2 Global Non-invasive Vagus Nerve Stimulator Revenue and Market Share by Application (2021-2026)
2.4.7.3 Global Non-invasive Vagus Nerve Stimulator Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Non-invasive Vagus Nerve Stimulator Breakdown Data by Company
3.1.1 Global Non-invasive Vagus Nerve Stimulator Annual Sales by Company (2021-2026)
3.1.2 Global Non-invasive Vagus Nerve Stimulator Sales Market Share by Company (2021-2026)
3.2 Global Non-invasive Vagus Nerve Stimulator Annual Revenue by Company (2021-2026)
3.2.1 Global Non-invasive Vagus Nerve Stimulator Revenue by Company (2021-2026)
3.2.2 Global Non-invasive Vagus Nerve Stimulator Revenue Market Share by Company (2021-2026)
3.3 Global Non-invasive Vagus Nerve Stimulator Sale Price by Company
3.4 Key Manufacturers Non-invasive Vagus Nerve Stimulator Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Non-invasive Vagus Nerve Stimulator Product Location Distribution
3.4.2 Players Non-invasive Vagus Nerve Stimulator Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR NON-INVASIVE VAGUS NERVE STIMULATOR BY GEOGRAPHIC REGION
4.1 World Historic Non-invasive Vagus Nerve Stimulator Market Size by Geographic Region (2021-2026)
4.1.1 Global Non-invasive Vagus Nerve Stimulator Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Non-invasive Vagus Nerve Stimulator Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Non-invasive Vagus Nerve Stimulator Market Size by Country/Region (2021-2026)
4.2.1 Global Non-invasive Vagus Nerve Stimulator Annual Sales by Country/Region (2021-2026)
4.2.2 Global Non-invasive Vagus Nerve Stimulator Annual Revenue by Country/Region (2021-2026)
4.3 Americas Non-invasive Vagus Nerve Stimulator Sales Growth
4.4 APAC Non-invasive Vagus Nerve Stimulator Sales Growth
4.5 Europe Non-invasive Vagus Nerve Stimulator Sales Growth
4.6 Middle East & Africa Non-invasive Vagus Nerve Stimulator Sales Growth
5 AMERICAS
5.1 Americas Non-invasive Vagus Nerve Stimulator Sales by Country
5.1.1 Americas Non-invasive Vagus Nerve Stimulator Sales by Country (2021-2026)
5.1.2 Americas Non-invasive Vagus Nerve Stimulator Revenue by Country (2021-2026)
5.2 Americas Non-invasive Vagus Nerve Stimulator Sales by Technology Route (2021-2026)
5.3 Americas Non-invasive Vagus Nerve Stimulator Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Non-invasive Vagus Nerve Stimulator Sales by Region
6.1.1 APAC Non-invasive Vagus Nerve Stimulator Sales by Region (2021-2026)
6.1.2 APAC Non-invasive Vagus Nerve Stimulator Revenue by Region (2021-2026)
6.2 APAC Non-invasive Vagus Nerve Stimulator Sales by Technology Route (2021-2026)
6.3 APAC Non-invasive Vagus Nerve Stimulator Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Non-invasive Vagus Nerve Stimulator by Country
7.1.1 Europe Non-invasive Vagus Nerve Stimulator Sales by Country (2021-2026)
7.1.2 Europe Non-invasive Vagus Nerve Stimulator Revenue by Country (2021-2026)
7.2 Europe Non-invasive Vagus Nerve Stimulator Sales by Technology Route (2021-2026)
7.3 Europe Non-invasive Vagus Nerve Stimulator Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Non-invasive Vagus Nerve Stimulator by Country
8.1.1 Middle East & Africa Non-invasive Vagus Nerve Stimulator Sales by Country (2021-2026)
8.1.2 Middle East & Africa Non-invasive Vagus Nerve Stimulator Revenue by Country (2021-2026)
8.2 Middle East & Africa Non-invasive Vagus Nerve Stimulator Sales by Technology Route (2021-2026)
8.3 Middle East & Africa Non-invasive Vagus Nerve Stimulator Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Non-invasive Vagus Nerve Stimulator
10.3 Manufacturing Process Analysis of Non-invasive Vagus Nerve Stimulator
10.4 Industry Chain Structure of Non-invasive Vagus Nerve Stimulator
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Non-invasive Vagus Nerve Stimulator Distributors
11.3 Non-invasive Vagus Nerve Stimulator Customer
12 WORLD FORECAST REVIEW FOR NON-INVASIVE VAGUS NERVE STIMULATOR BY GEOGRAPHIC REGION
12.1 Global Non-invasive Vagus Nerve Stimulator Market Size Forecast by Region
12.1.1 Global Non-invasive Vagus Nerve Stimulator Forecast by Region (2027-2032)
12.1.2 Global Non-invasive Vagus Nerve Stimulator Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Non-invasive Vagus Nerve Stimulator Forecast by Technology Route (2027-2032)
12.7 Global Non-invasive Vagus Nerve Stimulator Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 electroCore, Inc.
13.1.1 electroCore, Inc. Company Information
13.1.2 electroCore, Inc. Non-invasive Vagus Nerve Stimulator Product Portfolios and Specifications
13.1.3 electroCore, Inc. Non-invasive Vagus Nerve Stimulator Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 electroCore, Inc. Main Business Overview
13.1.5 electroCore, Inc. Latest Developments
13.2 Parasym Ltd.
13.2.1 Parasym Ltd. Company Information
13.2.2 Parasym Ltd. Non-invasive Vagus Nerve Stimulator Product Portfolios and Specifications
13.2.3 Parasym Ltd. Non-invasive Vagus Nerve Stimulator Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Parasym Ltd. Main Business Overview
13.2.5 Parasym Ltd. Latest Developments
13.3 tVNS Technologies GmbH
13.3.1 tVNS Technologies GmbH Company Information
13.3.2 tVNS Technologies GmbH Non-invasive Vagus Nerve Stimulator Product Portfolios and Specifications
13.3.3 tVNS Technologies GmbH Non-invasive Vagus Nerve Stimulator Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 tVNS Technologies GmbH Main Business Overview
13.3.5 tVNS Technologies GmbH Latest Developments
13.4 NEMOS GmbH
13.4.1 NEMOS GmbH Company Information
13.4.2 NEMOS GmbH Non-invasive Vagus Nerve Stimulator Product Portfolios and Specifications
13.4.3 NEMOS GmbH Non-invasive Vagus Nerve Stimulator Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 NEMOS GmbH Main Business Overview
13.4.5 NEMOS GmbH Latest Developments
13.5 NeuroSigma, Inc.
13.5.1 NeuroSigma, Inc. Company Information
13.5.2 NeuroSigma, Inc. Non-invasive Vagus Nerve Stimulator Product Portfolios and Specifications
13.5.3 NeuroSigma, Inc. Non-invasive Vagus Nerve Stimulator Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 NeuroSigma, Inc. Main Business Overview
13.5.5 NeuroSigma, Inc. Latest Developments
13.6 Jiangsu Yuyue Medical Equipment & Supply Co., Ltd.
13.6.1 Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. Company Information
13.6.2 Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. Non-invasive Vagus Nerve Stimulator Product Portfolios and Specifications
13.6.3 Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. Non-invasive Vagus Nerve Stimulator Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. Main Business Overview
13.6.5 Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. Latest Developments
13.7 Jiangxi Xinzhile Medical Technology Co., Ltd.
13.7.1 Jiangxi Xinzhile Medical Technology Co., Ltd. Company Information
13.7.2 Jiangxi Xinzhile Medical Technology Co., Ltd. Non-invasive Vagus Nerve Stimulator Product Portfolios and Specifications
13.7.3 Jiangxi Xinzhile Medical Technology Co., Ltd. Non-invasive Vagus Nerve Stimulator Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Jiangxi Xinzhile Medical Technology Co., Ltd. Main Business Overview
13.7.5 Jiangxi Xinzhile Medical Technology Co., Ltd. Latest Developments
13.8 Hangzhou Yijian Technology Co., Ltd.
13.8.1 Hangzhou Yijian Technology Co., Ltd. Company Information
13.8.2 Hangzhou Yijian Technology Co., Ltd. Non-invasive Vagus Nerve Stimulator Product Portfolios and Specifications
13.8.3 Hangzhou Yijian Technology Co., Ltd. Non-invasive Vagus Nerve Stimulator Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Hangzhou Yijian Technology Co., Ltd. Main Business Overview
13.8.5 Hangzhou Yijian Technology Co., Ltd. Latest Developments
13.9 Hangzhou Raloway Technology Co., Ltd.
13.9.1 Hangzhou Raloway Technology Co., Ltd. Company Information
13.9.2 Hangzhou Raloway Technology Co., Ltd. Non-invasive Vagus Nerve Stimulator Product Portfolios and Specifications
13.9.3 Hangzhou Raloway Technology Co., Ltd. Non-invasive Vagus Nerve Stimulator Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Hangzhou Raloway Technology Co., Ltd. Main Business Overview
13.9.5 Hangzhou Raloway Technology Co., Ltd. Latest Developments
13.10 NEURIVE Co., Ltd.
13.10.1 NEURIVE Co., Ltd. Company Information
13.10.2 NEURIVE Co., Ltd. Non-invasive Vagus Nerve Stimulator Product Portfolios and Specifications
13.10.3 NEURIVE Co., Ltd. Non-invasive Vagus Nerve Stimulator Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 NEURIVE Co., Ltd. Main Business Overview
13.10.5 NEURIVE Co., Ltd. Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Non-invasive Vagus Nerve Stimulator Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Non-invasive Vagus Nerve Stimulator by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Non-invasive Vagus Nerve Stimulator by Country/Region, 2021, 2025 & 2032
2.2 Non-invasive Vagus Nerve Stimulator Segment by Technology Route
2.2.1 Transcutaneous Cervical Vagus Nerve Stimulation (tcVNS)
2.2.2 Transcutaneous Auricular Vagus Nerve Stimulation (taVNS)
2.2.3 Others
2.2.4 Non-invasive Vagus Nerve Stimulator Sales by Technology Route
2.2.4.1 Global Non-invasive Vagus Nerve Stimulator Sales Market Share by Technology Route (2021-2026)
2.2.4.2 Global Non-invasive Vagus Nerve Stimulator Revenue and Market Share by Technology Route (2021-2026)
2.2.4.3 Global Non-invasive Vagus Nerve Stimulator Sale Price by Technology Route (2021-2026)
2.3 Non-invasive Vagus Nerve Stimulator Segment by Product Form
2.3.1 Portable Handheld Devices
2.3.2 Wearable Devices
2.3.3 Others
2.3.4 Non-invasive Vagus Nerve Stimulator Sales by Product Form
2.3.4.1 Global Non-invasive Vagus Nerve Stimulator Sales Market Share by Product Form (2021-2026)
2.3.4.2 Global Non-invasive Vagus Nerve Stimulator Revenue and Market Share by Product Form (2021-2026)
2.3.4.3 Global Non-invasive Vagus Nerve Stimulator Sale Price by Product Form (2021-2026)
2.4 Non-invasive Vagus Nerve Stimulator Segment by Application
2.4.1 Neurological Disorders
2.4.2 Mental Health Disorders
2.4.3 Pain Management
2.4.4 Sleep Disorders
2.4.5 Inflammation and Autonomic Regulation
2.4.6 Others
2.4.7 Non-invasive Vagus Nerve Stimulator Sales by Application
2.4.7.1 Global Non-invasive Vagus Nerve Stimulator Sale Market Share by Application (2021-2026)
2.4.7.2 Global Non-invasive Vagus Nerve Stimulator Revenue and Market Share by Application (2021-2026)
2.4.7.3 Global Non-invasive Vagus Nerve Stimulator Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Non-invasive Vagus Nerve Stimulator Breakdown Data by Company
3.1.1 Global Non-invasive Vagus Nerve Stimulator Annual Sales by Company (2021-2026)
3.1.2 Global Non-invasive Vagus Nerve Stimulator Sales Market Share by Company (2021-2026)
3.2 Global Non-invasive Vagus Nerve Stimulator Annual Revenue by Company (2021-2026)
3.2.1 Global Non-invasive Vagus Nerve Stimulator Revenue by Company (2021-2026)
3.2.2 Global Non-invasive Vagus Nerve Stimulator Revenue Market Share by Company (2021-2026)
3.3 Global Non-invasive Vagus Nerve Stimulator Sale Price by Company
3.4 Key Manufacturers Non-invasive Vagus Nerve Stimulator Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Non-invasive Vagus Nerve Stimulator Product Location Distribution
3.4.2 Players Non-invasive Vagus Nerve Stimulator Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR NON-INVASIVE VAGUS NERVE STIMULATOR BY GEOGRAPHIC REGION
4.1 World Historic Non-invasive Vagus Nerve Stimulator Market Size by Geographic Region (2021-2026)
4.1.1 Global Non-invasive Vagus Nerve Stimulator Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Non-invasive Vagus Nerve Stimulator Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Non-invasive Vagus Nerve Stimulator Market Size by Country/Region (2021-2026)
4.2.1 Global Non-invasive Vagus Nerve Stimulator Annual Sales by Country/Region (2021-2026)
4.2.2 Global Non-invasive Vagus Nerve Stimulator Annual Revenue by Country/Region (2021-2026)
4.3 Americas Non-invasive Vagus Nerve Stimulator Sales Growth
4.4 APAC Non-invasive Vagus Nerve Stimulator Sales Growth
4.5 Europe Non-invasive Vagus Nerve Stimulator Sales Growth
4.6 Middle East & Africa Non-invasive Vagus Nerve Stimulator Sales Growth
5 AMERICAS
5.1 Americas Non-invasive Vagus Nerve Stimulator Sales by Country
5.1.1 Americas Non-invasive Vagus Nerve Stimulator Sales by Country (2021-2026)
5.1.2 Americas Non-invasive Vagus Nerve Stimulator Revenue by Country (2021-2026)
5.2 Americas Non-invasive Vagus Nerve Stimulator Sales by Technology Route (2021-2026)
5.3 Americas Non-invasive Vagus Nerve Stimulator Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Non-invasive Vagus Nerve Stimulator Sales by Region
6.1.1 APAC Non-invasive Vagus Nerve Stimulator Sales by Region (2021-2026)
6.1.2 APAC Non-invasive Vagus Nerve Stimulator Revenue by Region (2021-2026)
6.2 APAC Non-invasive Vagus Nerve Stimulator Sales by Technology Route (2021-2026)
6.3 APAC Non-invasive Vagus Nerve Stimulator Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Non-invasive Vagus Nerve Stimulator by Country
7.1.1 Europe Non-invasive Vagus Nerve Stimulator Sales by Country (2021-2026)
7.1.2 Europe Non-invasive Vagus Nerve Stimulator Revenue by Country (2021-2026)
7.2 Europe Non-invasive Vagus Nerve Stimulator Sales by Technology Route (2021-2026)
7.3 Europe Non-invasive Vagus Nerve Stimulator Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Non-invasive Vagus Nerve Stimulator by Country
8.1.1 Middle East & Africa Non-invasive Vagus Nerve Stimulator Sales by Country (2021-2026)
8.1.2 Middle East & Africa Non-invasive Vagus Nerve Stimulator Revenue by Country (2021-2026)
8.2 Middle East & Africa Non-invasive Vagus Nerve Stimulator Sales by Technology Route (2021-2026)
8.3 Middle East & Africa Non-invasive Vagus Nerve Stimulator Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Non-invasive Vagus Nerve Stimulator
10.3 Manufacturing Process Analysis of Non-invasive Vagus Nerve Stimulator
10.4 Industry Chain Structure of Non-invasive Vagus Nerve Stimulator
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Non-invasive Vagus Nerve Stimulator Distributors
11.3 Non-invasive Vagus Nerve Stimulator Customer
12 WORLD FORECAST REVIEW FOR NON-INVASIVE VAGUS NERVE STIMULATOR BY GEOGRAPHIC REGION
12.1 Global Non-invasive Vagus Nerve Stimulator Market Size Forecast by Region
12.1.1 Global Non-invasive Vagus Nerve Stimulator Forecast by Region (2027-2032)
12.1.2 Global Non-invasive Vagus Nerve Stimulator Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Non-invasive Vagus Nerve Stimulator Forecast by Technology Route (2027-2032)
12.7 Global Non-invasive Vagus Nerve Stimulator Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 electroCore, Inc.
13.1.1 electroCore, Inc. Company Information
13.1.2 electroCore, Inc. Non-invasive Vagus Nerve Stimulator Product Portfolios and Specifications
13.1.3 electroCore, Inc. Non-invasive Vagus Nerve Stimulator Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 electroCore, Inc. Main Business Overview
13.1.5 electroCore, Inc. Latest Developments
13.2 Parasym Ltd.
13.2.1 Parasym Ltd. Company Information
13.2.2 Parasym Ltd. Non-invasive Vagus Nerve Stimulator Product Portfolios and Specifications
13.2.3 Parasym Ltd. Non-invasive Vagus Nerve Stimulator Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Parasym Ltd. Main Business Overview
13.2.5 Parasym Ltd. Latest Developments
13.3 tVNS Technologies GmbH
13.3.1 tVNS Technologies GmbH Company Information
13.3.2 tVNS Technologies GmbH Non-invasive Vagus Nerve Stimulator Product Portfolios and Specifications
13.3.3 tVNS Technologies GmbH Non-invasive Vagus Nerve Stimulator Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 tVNS Technologies GmbH Main Business Overview
13.3.5 tVNS Technologies GmbH Latest Developments
13.4 NEMOS GmbH
13.4.1 NEMOS GmbH Company Information
13.4.2 NEMOS GmbH Non-invasive Vagus Nerve Stimulator Product Portfolios and Specifications
13.4.3 NEMOS GmbH Non-invasive Vagus Nerve Stimulator Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 NEMOS GmbH Main Business Overview
13.4.5 NEMOS GmbH Latest Developments
13.5 NeuroSigma, Inc.
13.5.1 NeuroSigma, Inc. Company Information
13.5.2 NeuroSigma, Inc. Non-invasive Vagus Nerve Stimulator Product Portfolios and Specifications
13.5.3 NeuroSigma, Inc. Non-invasive Vagus Nerve Stimulator Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 NeuroSigma, Inc. Main Business Overview
13.5.5 NeuroSigma, Inc. Latest Developments
13.6 Jiangsu Yuyue Medical Equipment & Supply Co., Ltd.
13.6.1 Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. Company Information
13.6.2 Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. Non-invasive Vagus Nerve Stimulator Product Portfolios and Specifications
13.6.3 Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. Non-invasive Vagus Nerve Stimulator Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. Main Business Overview
13.6.5 Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. Latest Developments
13.7 Jiangxi Xinzhile Medical Technology Co., Ltd.
13.7.1 Jiangxi Xinzhile Medical Technology Co., Ltd. Company Information
13.7.2 Jiangxi Xinzhile Medical Technology Co., Ltd. Non-invasive Vagus Nerve Stimulator Product Portfolios and Specifications
13.7.3 Jiangxi Xinzhile Medical Technology Co., Ltd. Non-invasive Vagus Nerve Stimulator Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Jiangxi Xinzhile Medical Technology Co., Ltd. Main Business Overview
13.7.5 Jiangxi Xinzhile Medical Technology Co., Ltd. Latest Developments
13.8 Hangzhou Yijian Technology Co., Ltd.
13.8.1 Hangzhou Yijian Technology Co., Ltd. Company Information
13.8.2 Hangzhou Yijian Technology Co., Ltd. Non-invasive Vagus Nerve Stimulator Product Portfolios and Specifications
13.8.3 Hangzhou Yijian Technology Co., Ltd. Non-invasive Vagus Nerve Stimulator Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Hangzhou Yijian Technology Co., Ltd. Main Business Overview
13.8.5 Hangzhou Yijian Technology Co., Ltd. Latest Developments
13.9 Hangzhou Raloway Technology Co., Ltd.
13.9.1 Hangzhou Raloway Technology Co., Ltd. Company Information
13.9.2 Hangzhou Raloway Technology Co., Ltd. Non-invasive Vagus Nerve Stimulator Product Portfolios and Specifications
13.9.3 Hangzhou Raloway Technology Co., Ltd. Non-invasive Vagus Nerve Stimulator Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Hangzhou Raloway Technology Co., Ltd. Main Business Overview
13.9.5 Hangzhou Raloway Technology Co., Ltd. Latest Developments
13.10 NEURIVE Co., Ltd.
13.10.1 NEURIVE Co., Ltd. Company Information
13.10.2 NEURIVE Co., Ltd. Non-invasive Vagus Nerve Stimulator Product Portfolios and Specifications
13.10.3 NEURIVE Co., Ltd. Non-invasive Vagus Nerve Stimulator Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 NEURIVE Co., Ltd. Main Business Overview
13.10.5 NEURIVE Co., Ltd. Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Non-invasive Vagus Nerve Stimulator Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Non-invasive Vagus Nerve Stimulator Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Transcutaneous Cervical Vagus Nerve Stimulation (tcVNS)
Table 4. Major Players of Transcutaneous Auricular Vagus Nerve Stimulation (taVNS)
Table 5. Major Players of Others
Table 6. Global Non-invasive Vagus Nerve Stimulator Sales by Technology Route (2021-2026) & (Units)
Table 7. Global Non-invasive Vagus Nerve Stimulator Sales Market Share by Technology Route (2021-2026)
Table 8. Global Non-invasive Vagus Nerve Stimulator Revenue by Technology Route (2021-2026) & ($ million)
Table 9. Global Non-invasive Vagus Nerve Stimulator Revenue Market Share by Technology Route (2021-2026)
Table 10. Global Non-invasive Vagus Nerve Stimulator Sale Price by Technology Route (2021-2026) & (K US$/Unit)
Table 11. Major Players of Portable Handheld Devices
Table 12. Major Players of Wearable Devices
Table 13. Major Players of Others
Table 14. Global Non-invasive Vagus Nerve Stimulator Sales by Product Form (2021-2026) & (Units)
Table 15. Global Non-invasive Vagus Nerve Stimulator Sales Market Share by Product Form (2021-2026)
Table 16. Global Non-invasive Vagus Nerve Stimulator Revenue by Product Form (2021-2026) & ($ million)
Table 17. Global Non-invasive Vagus Nerve Stimulator Revenue Market Share by Product Form (2021-2026)
Table 18. Global Non-invasive Vagus Nerve Stimulator Sale Price by Product Form (2021-2026) & (K US$/Unit)
Table 19. Global Non-invasive Vagus Nerve Stimulator Sale by Application (2021-2026) & (Units)
Table 20. Global Non-invasive Vagus Nerve Stimulator Sale Market Share by Application (2021-2026)
Table 21. Global Non-invasive Vagus Nerve Stimulator Revenue by Application (2021-2026) & ($ million)
Table 22. Global Non-invasive Vagus Nerve Stimulator Revenue Market Share by Application (2021-2026)
Table 23. Global Non-invasive Vagus Nerve Stimulator Sale Price by Application (2021-2026) & (K US$/Unit)
Table 24. Global Non-invasive Vagus Nerve Stimulator Sales by Company (2021-2026) & (Units)
Table 25. Global Non-invasive Vagus Nerve Stimulator Sales Market Share by Company (2021-2026)
Table 26. Global Non-invasive Vagus Nerve Stimulator Revenue by Company (2021-2026) & ($ millions)
Table 27. Global Non-invasive Vagus Nerve Stimulator Revenue Market Share by Company (2021-2026)
Table 28. Global Non-invasive Vagus Nerve Stimulator Sale Price by Company (2021-2026) & (K US$/Unit)
Table 29. Key Manufacturers Non-invasive Vagus Nerve Stimulator Producing Area Distribution and Sales Area
Table 30. Players Non-invasive Vagus Nerve Stimulator Products Offered
Table 31. Non-invasive Vagus Nerve Stimulator Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 32. New Products and Potential Entrants
Table 33. Market M&A Activity & Strategy
Table 34. Global Non-invasive Vagus Nerve Stimulator Sales by Geographic Region (2021-2026) & (Units)
Table 35. Global Non-invasive Vagus Nerve Stimulator Sales Market Share Geographic Region (2021-2026)
Table 36. Global Non-invasive Vagus Nerve Stimulator Revenue by Geographic Region (2021-2026) & ($ millions)
Table 37. Global Non-invasive Vagus Nerve Stimulator Revenue Market Share by Geographic Region (2021-2026)
Table 38. Global Non-invasive Vagus Nerve Stimulator Sales by Country/Region (2021-2026) & (Units)
Table 39. Global Non-invasive Vagus Nerve Stimulator Sales Market Share by Country/Region (2021-2026)
Table 40. Global Non-invasive Vagus Nerve Stimulator Revenue by Country/Region (2021-2026) & ($ millions)
Table 41. Global Non-invasive Vagus Nerve Stimulator Revenue Market Share by Country/Region (2021-2026)
Table 42. Americas Non-invasive Vagus Nerve Stimulator Sales by Country (2021-2026) & (Units)
Table 43. Americas Non-invasive Vagus Nerve Stimulator Sales Market Share by Country (2021-2026)
Table 44. Americas Non-invasive Vagus Nerve Stimulator Revenue by Country (2021-2026) & ($ millions)
Table 45. Americas Non-invasive Vagus Nerve Stimulator Sales by Technology Route (2021-2026) & (Units)
Table 46. Americas Non-invasive Vagus Nerve Stimulator Sales by Application (2021-2026) & (Units)
Table 47. APAC Non-invasive Vagus Nerve Stimulator Sales by Region (2021-2026) & (Units)
Table 48. APAC Non-invasive Vagus Nerve Stimulator Sales Market Share by Region (2021-2026)
Table 49. APAC Non-invasive Vagus Nerve Stimulator Revenue by Region (2021-2026) & ($ millions)
Table 50. APAC Non-invasive Vagus Nerve Stimulator Sales by Technology Route (2021-2026) & (Units)
Table 51. APAC Non-invasive Vagus Nerve Stimulator Sales by Application (2021-2026) & (Units)
Table 52. Europe Non-invasive Vagus Nerve Stimulator Sales by Country (2021-2026) & (Units)
Table 53. Europe Non-invasive Vagus Nerve Stimulator Revenue by Country (2021-2026) & ($ millions)
Table 54. Europe Non-invasive Vagus Nerve Stimulator Sales by Technology Route (2021-2026) & (Units)
Table 55. Europe Non-invasive Vagus Nerve Stimulator Sales by Application (2021-2026) & (Units)
Table 56. Middle East & Africa Non-invasive Vagus Nerve Stimulator Sales by Country (2021-2026) & (Units)
Table 57. Middle East & Africa Non-invasive Vagus Nerve Stimulator Revenue Market Share by Country (2021-2026)
Table 58. Middle East & Africa Non-invasive Vagus Nerve Stimulator Sales by Technology Route (2021-2026) & (Units)
Table 59. Middle East & Africa Non-invasive Vagus Nerve Stimulator Sales by Application (2021-2026) & (Units)
Table 60. Key Market Drivers & Growth Opportunities of Non-invasive Vagus Nerve Stimulator
Table 61. Key Market Challenges & Risks of Non-invasive Vagus Nerve Stimulator
Table 62. Key Industry Trends of Non-invasive Vagus Nerve Stimulator
Table 63. Non-invasive Vagus Nerve Stimulator Raw Material
Table 64. Key Suppliers of Raw Materials
Table 65. Non-invasive Vagus Nerve Stimulator Distributors List
Table 66. Non-invasive Vagus Nerve Stimulator Customer List
Table 67. Global Non-invasive Vagus Nerve Stimulator Sales Forecast by Region (2027-2032) & (Units)
Table 68. Global Non-invasive Vagus Nerve Stimulator Revenue Forecast by Region (2027-2032) & ($ millions)
Table 69. Americas Non-invasive Vagus Nerve Stimulator Sales Forecast by Country (2027-2032) & (Units)
Table 70. Americas Non-invasive Vagus Nerve Stimulator Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 71. APAC Non-invasive Vagus Nerve Stimulator Sales Forecast by Region (2027-2032) & (Units)
Table 72. APAC Non-invasive Vagus Nerve Stimulator Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 73. Europe Non-invasive Vagus Nerve Stimulator Sales Forecast by Country (2027-2032) & (Units)
Table 74. Europe Non-invasive Vagus Nerve Stimulator Revenue Forecast by Country (2027-2032) & ($ millions)
Table 75. Middle East & Africa Non-invasive Vagus Nerve Stimulator Sales Forecast by Country (2027-2032) & (Units)
Table 76. Middle East & Africa Non-invasive Vagus Nerve Stimulator Revenue Forecast by Country (2027-2032) & ($ millions)
Table 77. Global Non-invasive Vagus Nerve Stimulator Sales Forecast by Technology Route (2027-2032) & (Units)
Table 78. Global Non-invasive Vagus Nerve Stimulator Revenue Forecast by Technology Route (2027-2032) & ($ millions)
Table 79. Global Non-invasive Vagus Nerve Stimulator Sales Forecast by Application (2027-2032) & (Units)
Table 80. Global Non-invasive Vagus Nerve Stimulator Revenue Forecast by Application (2027-2032) & ($ millions)
Table 81. electroCore, Inc. Basic Information, Non-invasive Vagus Nerve Stimulator Manufacturing Base, Sales Area and Its Competitors
Table 82. electroCore, Inc. Non-invasive Vagus Nerve Stimulator Product Portfolios and Specifications
Table 83. electroCore, Inc. Non-invasive Vagus Nerve Stimulator Sales (Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 84. electroCore, Inc. Main Business
Table 85. electroCore, Inc. Latest Developments
Table 86. Parasym Ltd. Basic Information, Non-invasive Vagus Nerve Stimulator Manufacturing Base, Sales Area and Its Competitors
Table 87. Parasym Ltd. Non-invasive Vagus Nerve Stimulator Product Portfolios and Specifications
Table 88. Parasym Ltd. Non-invasive Vagus Nerve Stimulator Sales (Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 89. Parasym Ltd. Main Business
Table 90. Parasym Ltd. Latest Developments
Table 91. tVNS Technologies GmbH Basic Information, Non-invasive Vagus Nerve Stimulator Manufacturing Base, Sales Area and Its Competitors
Table 92. tVNS Technologies GmbH Non-invasive Vagus Nerve Stimulator Product Portfolios and Specifications
Table 93. tVNS Technologies GmbH Non-invasive Vagus Nerve Stimulator Sales (Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 94. tVNS Technologies GmbH Main Business
Table 95. tVNS Technologies GmbH Latest Developments
Table 96. NEMOS GmbH Basic Information, Non-invasive Vagus Nerve Stimulator Manufacturing Base, Sales Area and Its Competitors
Table 97. NEMOS GmbH Non-invasive Vagus Nerve Stimulator Product Portfolios and Specifications
Table 98. NEMOS GmbH Non-invasive Vagus Nerve Stimulator Sales (Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 99. NEMOS GmbH Main Business
Table 100. NEMOS GmbH Latest Developments
Table 101. NeuroSigma, Inc. Basic Information, Non-invasive Vagus Nerve Stimulator Manufacturing Base, Sales Area and Its Competitors
Table 102. NeuroSigma, Inc. Non-invasive Vagus Nerve Stimulator Product Portfolios and Specifications
Table 103. NeuroSigma, Inc. Non-invasive Vagus Nerve Stimulator Sales (Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 104. NeuroSigma, Inc. Main Business
Table 105. NeuroSigma, Inc. Latest Developments
Table 106. Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. Basic Information, Non-invasive Vagus Nerve Stimulator Manufacturing Base, Sales Area and Its Competitors
Table 107. Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. Non-invasive Vagus Nerve Stimulator Product Portfolios and Specifications
Table 108. Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. Non-invasive Vagus Nerve Stimulator Sales (Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 109. Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. Main Business
Table 110. Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. Latest Developments
Table 111. Jiangxi Xinzhile Medical Technology Co., Ltd. Basic Information, Non-invasive Vagus Nerve Stimulator Manufacturing Base, Sales Area and Its Competitors
Table 112. Jiangxi Xinzhile Medical Technology Co., Ltd. Non-invasive Vagus Nerve Stimulator Product Portfolios and Specifications
Table 113. Jiangxi Xinzhile Medical Technology Co., Ltd. Non-invasive Vagus Nerve Stimulator Sales (Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 114. Jiangxi Xinzhile Medical Technology Co., Ltd. Main Business
Table 115. Jiangxi Xinzhile Medical Technology Co., Ltd. Latest Developments
Table 116. Hangzhou Yijian Technology Co., Ltd. Basic Information, Non-invasive Vagus Nerve Stimulator Manufacturing Base, Sales Area and Its Competitors
Table 117. Hangzhou Yijian Technology Co., Ltd. Non-invasive Vagus Nerve Stimulator Product Portfolios and Specifications
Table 118. Hangzhou Yijian Technology Co., Ltd. Non-invasive Vagus Nerve Stimulator Sales (Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 119. Hangzhou Yijian Technology Co., Ltd. Main Business
Table 120. Hangzhou Yijian Technology Co., Ltd. Latest Developments
Table 121. Hangzhou Raloway Technology Co., Ltd. Basic Information, Non-invasive Vagus Nerve Stimulator Manufacturing Base, Sales Area and Its Competitors
Table 122. Hangzhou Raloway Technology Co., Ltd. Non-invasive Vagus Nerve Stimulator Product Portfolios and Specifications
Table 123. Hangzhou Raloway Technology Co., Ltd. Non-invasive Vagus Nerve Stimulator Sales (Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 124. Hangzhou Raloway Technology Co., Ltd. Main Business
Table 125. Hangzhou Raloway Technology Co., Ltd. Latest Developments
Table 126. NEURIVE Co., Ltd. Basic Information, Non-invasive Vagus Nerve Stimulator Manufacturing Base, Sales Area and Its Competitors
Table 127. NEURIVE Co., Ltd. Non-invasive Vagus Nerve Stimulator Product Portfolios and Specifications
Table 128. NEURIVE Co., Ltd. Non-invasive Vagus Nerve Stimulator Sales (Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 129. NEURIVE Co., Ltd. Main Business
Table 130. NEURIVE Co., Ltd. Latest Developments
Table 1. Non-invasive Vagus Nerve Stimulator Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Non-invasive Vagus Nerve Stimulator Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Transcutaneous Cervical Vagus Nerve Stimulation (tcVNS)
Table 4. Major Players of Transcutaneous Auricular Vagus Nerve Stimulation (taVNS)
Table 5. Major Players of Others
Table 6. Global Non-invasive Vagus Nerve Stimulator Sales by Technology Route (2021-2026) & (Units)
Table 7. Global Non-invasive Vagus Nerve Stimulator Sales Market Share by Technology Route (2021-2026)
Table 8. Global Non-invasive Vagus Nerve Stimulator Revenue by Technology Route (2021-2026) & ($ million)
Table 9. Global Non-invasive Vagus Nerve Stimulator Revenue Market Share by Technology Route (2021-2026)
Table 10. Global Non-invasive Vagus Nerve Stimulator Sale Price by Technology Route (2021-2026) & (K US$/Unit)
Table 11. Major Players of Portable Handheld Devices
Table 12. Major Players of Wearable Devices
Table 13. Major Players of Others
Table 14. Global Non-invasive Vagus Nerve Stimulator Sales by Product Form (2021-2026) & (Units)
Table 15. Global Non-invasive Vagus Nerve Stimulator Sales Market Share by Product Form (2021-2026)
Table 16. Global Non-invasive Vagus Nerve Stimulator Revenue by Product Form (2021-2026) & ($ million)
Table 17. Global Non-invasive Vagus Nerve Stimulator Revenue Market Share by Product Form (2021-2026)
Table 18. Global Non-invasive Vagus Nerve Stimulator Sale Price by Product Form (2021-2026) & (K US$/Unit)
Table 19. Global Non-invasive Vagus Nerve Stimulator Sale by Application (2021-2026) & (Units)
Table 20. Global Non-invasive Vagus Nerve Stimulator Sale Market Share by Application (2021-2026)
Table 21. Global Non-invasive Vagus Nerve Stimulator Revenue by Application (2021-2026) & ($ million)
Table 22. Global Non-invasive Vagus Nerve Stimulator Revenue Market Share by Application (2021-2026)
Table 23. Global Non-invasive Vagus Nerve Stimulator Sale Price by Application (2021-2026) & (K US$/Unit)
Table 24. Global Non-invasive Vagus Nerve Stimulator Sales by Company (2021-2026) & (Units)
Table 25. Global Non-invasive Vagus Nerve Stimulator Sales Market Share by Company (2021-2026)
Table 26. Global Non-invasive Vagus Nerve Stimulator Revenue by Company (2021-2026) & ($ millions)
Table 27. Global Non-invasive Vagus Nerve Stimulator Revenue Market Share by Company (2021-2026)
Table 28. Global Non-invasive Vagus Nerve Stimulator Sale Price by Company (2021-2026) & (K US$/Unit)
Table 29. Key Manufacturers Non-invasive Vagus Nerve Stimulator Producing Area Distribution and Sales Area
Table 30. Players Non-invasive Vagus Nerve Stimulator Products Offered
Table 31. Non-invasive Vagus Nerve Stimulator Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 32. New Products and Potential Entrants
Table 33. Market M&A Activity & Strategy
Table 34. Global Non-invasive Vagus Nerve Stimulator Sales by Geographic Region (2021-2026) & (Units)
Table 35. Global Non-invasive Vagus Nerve Stimulator Sales Market Share Geographic Region (2021-2026)
Table 36. Global Non-invasive Vagus Nerve Stimulator Revenue by Geographic Region (2021-2026) & ($ millions)
Table 37. Global Non-invasive Vagus Nerve Stimulator Revenue Market Share by Geographic Region (2021-2026)
Table 38. Global Non-invasive Vagus Nerve Stimulator Sales by Country/Region (2021-2026) & (Units)
Table 39. Global Non-invasive Vagus Nerve Stimulator Sales Market Share by Country/Region (2021-2026)
Table 40. Global Non-invasive Vagus Nerve Stimulator Revenue by Country/Region (2021-2026) & ($ millions)
Table 41. Global Non-invasive Vagus Nerve Stimulator Revenue Market Share by Country/Region (2021-2026)
Table 42. Americas Non-invasive Vagus Nerve Stimulator Sales by Country (2021-2026) & (Units)
Table 43. Americas Non-invasive Vagus Nerve Stimulator Sales Market Share by Country (2021-2026)
Table 44. Americas Non-invasive Vagus Nerve Stimulator Revenue by Country (2021-2026) & ($ millions)
Table 45. Americas Non-invasive Vagus Nerve Stimulator Sales by Technology Route (2021-2026) & (Units)
Table 46. Americas Non-invasive Vagus Nerve Stimulator Sales by Application (2021-2026) & (Units)
Table 47. APAC Non-invasive Vagus Nerve Stimulator Sales by Region (2021-2026) & (Units)
Table 48. APAC Non-invasive Vagus Nerve Stimulator Sales Market Share by Region (2021-2026)
Table 49. APAC Non-invasive Vagus Nerve Stimulator Revenue by Region (2021-2026) & ($ millions)
Table 50. APAC Non-invasive Vagus Nerve Stimulator Sales by Technology Route (2021-2026) & (Units)
Table 51. APAC Non-invasive Vagus Nerve Stimulator Sales by Application (2021-2026) & (Units)
Table 52. Europe Non-invasive Vagus Nerve Stimulator Sales by Country (2021-2026) & (Units)
Table 53. Europe Non-invasive Vagus Nerve Stimulator Revenue by Country (2021-2026) & ($ millions)
Table 54. Europe Non-invasive Vagus Nerve Stimulator Sales by Technology Route (2021-2026) & (Units)
Table 55. Europe Non-invasive Vagus Nerve Stimulator Sales by Application (2021-2026) & (Units)
Table 56. Middle East & Africa Non-invasive Vagus Nerve Stimulator Sales by Country (2021-2026) & (Units)
Table 57. Middle East & Africa Non-invasive Vagus Nerve Stimulator Revenue Market Share by Country (2021-2026)
Table 58. Middle East & Africa Non-invasive Vagus Nerve Stimulator Sales by Technology Route (2021-2026) & (Units)
Table 59. Middle East & Africa Non-invasive Vagus Nerve Stimulator Sales by Application (2021-2026) & (Units)
Table 60. Key Market Drivers & Growth Opportunities of Non-invasive Vagus Nerve Stimulator
Table 61. Key Market Challenges & Risks of Non-invasive Vagus Nerve Stimulator
Table 62. Key Industry Trends of Non-invasive Vagus Nerve Stimulator
Table 63. Non-invasive Vagus Nerve Stimulator Raw Material
Table 64. Key Suppliers of Raw Materials
Table 65. Non-invasive Vagus Nerve Stimulator Distributors List
Table 66. Non-invasive Vagus Nerve Stimulator Customer List
Table 67. Global Non-invasive Vagus Nerve Stimulator Sales Forecast by Region (2027-2032) & (Units)
Table 68. Global Non-invasive Vagus Nerve Stimulator Revenue Forecast by Region (2027-2032) & ($ millions)
Table 69. Americas Non-invasive Vagus Nerve Stimulator Sales Forecast by Country (2027-2032) & (Units)
Table 70. Americas Non-invasive Vagus Nerve Stimulator Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 71. APAC Non-invasive Vagus Nerve Stimulator Sales Forecast by Region (2027-2032) & (Units)
Table 72. APAC Non-invasive Vagus Nerve Stimulator Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 73. Europe Non-invasive Vagus Nerve Stimulator Sales Forecast by Country (2027-2032) & (Units)
Table 74. Europe Non-invasive Vagus Nerve Stimulator Revenue Forecast by Country (2027-2032) & ($ millions)
Table 75. Middle East & Africa Non-invasive Vagus Nerve Stimulator Sales Forecast by Country (2027-2032) & (Units)
Table 76. Middle East & Africa Non-invasive Vagus Nerve Stimulator Revenue Forecast by Country (2027-2032) & ($ millions)
Table 77. Global Non-invasive Vagus Nerve Stimulator Sales Forecast by Technology Route (2027-2032) & (Units)
Table 78. Global Non-invasive Vagus Nerve Stimulator Revenue Forecast by Technology Route (2027-2032) & ($ millions)
Table 79. Global Non-invasive Vagus Nerve Stimulator Sales Forecast by Application (2027-2032) & (Units)
Table 80. Global Non-invasive Vagus Nerve Stimulator Revenue Forecast by Application (2027-2032) & ($ millions)
Table 81. electroCore, Inc. Basic Information, Non-invasive Vagus Nerve Stimulator Manufacturing Base, Sales Area and Its Competitors
Table 82. electroCore, Inc. Non-invasive Vagus Nerve Stimulator Product Portfolios and Specifications
Table 83. electroCore, Inc. Non-invasive Vagus Nerve Stimulator Sales (Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 84. electroCore, Inc. Main Business
Table 85. electroCore, Inc. Latest Developments
Table 86. Parasym Ltd. Basic Information, Non-invasive Vagus Nerve Stimulator Manufacturing Base, Sales Area and Its Competitors
Table 87. Parasym Ltd. Non-invasive Vagus Nerve Stimulator Product Portfolios and Specifications
Table 88. Parasym Ltd. Non-invasive Vagus Nerve Stimulator Sales (Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 89. Parasym Ltd. Main Business
Table 90. Parasym Ltd. Latest Developments
Table 91. tVNS Technologies GmbH Basic Information, Non-invasive Vagus Nerve Stimulator Manufacturing Base, Sales Area and Its Competitors
Table 92. tVNS Technologies GmbH Non-invasive Vagus Nerve Stimulator Product Portfolios and Specifications
Table 93. tVNS Technologies GmbH Non-invasive Vagus Nerve Stimulator Sales (Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 94. tVNS Technologies GmbH Main Business
Table 95. tVNS Technologies GmbH Latest Developments
Table 96. NEMOS GmbH Basic Information, Non-invasive Vagus Nerve Stimulator Manufacturing Base, Sales Area and Its Competitors
Table 97. NEMOS GmbH Non-invasive Vagus Nerve Stimulator Product Portfolios and Specifications
Table 98. NEMOS GmbH Non-invasive Vagus Nerve Stimulator Sales (Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 99. NEMOS GmbH Main Business
Table 100. NEMOS GmbH Latest Developments
Table 101. NeuroSigma, Inc. Basic Information, Non-invasive Vagus Nerve Stimulator Manufacturing Base, Sales Area and Its Competitors
Table 102. NeuroSigma, Inc. Non-invasive Vagus Nerve Stimulator Product Portfolios and Specifications
Table 103. NeuroSigma, Inc. Non-invasive Vagus Nerve Stimulator Sales (Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 104. NeuroSigma, Inc. Main Business
Table 105. NeuroSigma, Inc. Latest Developments
Table 106. Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. Basic Information, Non-invasive Vagus Nerve Stimulator Manufacturing Base, Sales Area and Its Competitors
Table 107. Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. Non-invasive Vagus Nerve Stimulator Product Portfolios and Specifications
Table 108. Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. Non-invasive Vagus Nerve Stimulator Sales (Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 109. Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. Main Business
Table 110. Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. Latest Developments
Table 111. Jiangxi Xinzhile Medical Technology Co., Ltd. Basic Information, Non-invasive Vagus Nerve Stimulator Manufacturing Base, Sales Area and Its Competitors
Table 112. Jiangxi Xinzhile Medical Technology Co., Ltd. Non-invasive Vagus Nerve Stimulator Product Portfolios and Specifications
Table 113. Jiangxi Xinzhile Medical Technology Co., Ltd. Non-invasive Vagus Nerve Stimulator Sales (Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 114. Jiangxi Xinzhile Medical Technology Co., Ltd. Main Business
Table 115. Jiangxi Xinzhile Medical Technology Co., Ltd. Latest Developments
Table 116. Hangzhou Yijian Technology Co., Ltd. Basic Information, Non-invasive Vagus Nerve Stimulator Manufacturing Base, Sales Area and Its Competitors
Table 117. Hangzhou Yijian Technology Co., Ltd. Non-invasive Vagus Nerve Stimulator Product Portfolios and Specifications
Table 118. Hangzhou Yijian Technology Co., Ltd. Non-invasive Vagus Nerve Stimulator Sales (Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 119. Hangzhou Yijian Technology Co., Ltd. Main Business
Table 120. Hangzhou Yijian Technology Co., Ltd. Latest Developments
Table 121. Hangzhou Raloway Technology Co., Ltd. Basic Information, Non-invasive Vagus Nerve Stimulator Manufacturing Base, Sales Area and Its Competitors
Table 122. Hangzhou Raloway Technology Co., Ltd. Non-invasive Vagus Nerve Stimulator Product Portfolios and Specifications
Table 123. Hangzhou Raloway Technology Co., Ltd. Non-invasive Vagus Nerve Stimulator Sales (Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 124. Hangzhou Raloway Technology Co., Ltd. Main Business
Table 125. Hangzhou Raloway Technology Co., Ltd. Latest Developments
Table 126. NEURIVE Co., Ltd. Basic Information, Non-invasive Vagus Nerve Stimulator Manufacturing Base, Sales Area and Its Competitors
Table 127. NEURIVE Co., Ltd. Non-invasive Vagus Nerve Stimulator Product Portfolios and Specifications
Table 128. NEURIVE Co., Ltd. Non-invasive Vagus Nerve Stimulator Sales (Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 129. NEURIVE Co., Ltd. Main Business
Table 130. NEURIVE Co., Ltd. Latest Developments
LIST OF FIGURES
Figure 1. Picture of Non-invasive Vagus Nerve Stimulator
Figure 2. Non-invasive Vagus Nerve Stimulator Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Non-invasive Vagus Nerve Stimulator Sales Growth Rate 2021-2032 (Units)
Figure 7. Global Non-invasive Vagus Nerve Stimulator Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Non-invasive Vagus Nerve Stimulator Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Non-invasive Vagus Nerve Stimulator Sales Market Share by Country/Region (2025)
Figure 10. Non-invasive Vagus Nerve Stimulator Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Transcutaneous Cervical Vagus Nerve Stimulation (tcVNS)
Figure 12. Product Picture of Transcutaneous Auricular Vagus Nerve Stimulation (taVNS)
Figure 13. Product Picture of Others
Figure 14. Global Non-invasive Vagus Nerve Stimulator Sales Market Share by Technology Route in 2026
Figure 15. Global Non-invasive Vagus Nerve Stimulator Revenue Market Share by Technology Route (2021-2026)
Figure 16. Product Picture of Portable Handheld Devices
Figure 17. Product Picture of Wearable Devices
Figure 18. Product Picture of Others
Figure 19. Global Non-invasive Vagus Nerve Stimulator Sales Market Share by Product Form in 2026
Figure 20. Global Non-invasive Vagus Nerve Stimulator Revenue Market Share by Product Form (2021-2026)
Figure 21. Non-invasive Vagus Nerve Stimulator Consumed in Neurological Disorders
Figure 22. Global Non-invasive Vagus Nerve Stimulator Market: Neurological Disorders (2021-2026) & (Units)
Figure 23. Non-invasive Vagus Nerve Stimulator Consumed in Mental Health Disorders
Figure 24. Global Non-invasive Vagus Nerve Stimulator Market: Mental Health Disorders (2021-2026) & (Units)
Figure 25. Non-invasive Vagus Nerve Stimulator Consumed in Pain Management
Figure 26. Global Non-invasive Vagus Nerve Stimulator Market: Pain Management (2021-2026) & (Units)
Figure 27. Non-invasive Vagus Nerve Stimulator Consumed in Sleep Disorders
Figure 28. Global Non-invasive Vagus Nerve Stimulator Market: Sleep Disorders (2021-2026) & (Units)
Figure 29. Non-invasive Vagus Nerve Stimulator Consumed in Inflammation and Autonomic Regulation
Figure 30. Global Non-invasive Vagus Nerve Stimulator Market: Inflammation and Autonomic Regulation (2021-2026) & (Units)
Figure 31. Non-invasive Vagus Nerve Stimulator Consumed in Others
Figure 32. Global Non-invasive Vagus Nerve Stimulator Market: Others (2021-2026) & (Units)
Figure 33. Global Non-invasive Vagus Nerve Stimulator Sale Market Share by Application (2025)
Figure 34. Global Non-invasive Vagus Nerve Stimulator Revenue Market Share by Application in 2025
Figure 35. Non-invasive Vagus Nerve Stimulator Sales by Company in 2025 (Units)
Figure 36. Global Non-invasive Vagus Nerve Stimulator Sales Market Share by Company in 2025
Figure 37. Non-invasive Vagus Nerve Stimulator Revenue by Company in 2025 ($ millions)
Figure 38. Global Non-invasive Vagus Nerve Stimulator Revenue Market Share by Company in 2025
Figure 39. Global Non-invasive Vagus Nerve Stimulator Sales Market Share by Geographic Region (2021-2026)
Figure 40. Global Non-invasive Vagus Nerve Stimulator Revenue Market Share by Geographic Region in 2025
Figure 41. Americas Non-invasive Vagus Nerve Stimulator Sales 2021-2026 (Units)
Figure 42. Americas Non-invasive Vagus Nerve Stimulator Revenue 2021-2026 ($ millions)
Figure 43. APAC Non-invasive Vagus Nerve Stimulator Sales 2021-2026 (Units)
Figure 44. APAC Non-invasive Vagus Nerve Stimulator Revenue 2021-2026 ($ millions)
Figure 45. Europe Non-invasive Vagus Nerve Stimulator Sales 2021-2026 (Units)
Figure 46. Europe Non-invasive Vagus Nerve Stimulator Revenue 2021-2026 ($ millions)
Figure 47. Middle East & Africa Non-invasive Vagus Nerve Stimulator Sales 2021-2026 (Units)
Figure 48. Middle East & Africa Non-invasive Vagus Nerve Stimulator Revenue 2021-2026 ($ millions)
Figure 49. Americas Non-invasive Vagus Nerve Stimulator Sales Market Share by Country in 2025
Figure 50. Americas Non-invasive Vagus Nerve Stimulator Revenue Market Share by Country (2021-2026)
Figure 51. Americas Non-invasive Vagus Nerve Stimulator Sales Market Share by Technology Route (2021-2026)
Figure 52. Americas Non-invasive Vagus Nerve Stimulator Sales Market Share by Application (2021-2026)
Figure 53. United States Non-invasive Vagus Nerve Stimulator Revenue Growth 2021-2026 ($ millions)
Figure 54. Canada Non-invasive Vagus Nerve Stimulator Revenue Growth 2021-2026 ($ millions)
Figure 55. Mexico Non-invasive Vagus Nerve Stimulator Revenue Growth 2021-2026 ($ millions)
Figure 56. Brazil Non-invasive Vagus Nerve Stimulator Revenue Growth 2021-2026 ($ millions)
Figure 57. APAC Non-invasive Vagus Nerve Stimulator Sales Market Share by Region in 2025
Figure 58. APAC Non-invasive Vagus Nerve Stimulator Revenue Market Share by Region (2021-2026)
Figure 59. APAC Non-invasive Vagus Nerve Stimulator Sales Market Share by Technology Route (2021-2026)
Figure 60. APAC Non-invasive Vagus Nerve Stimulator Sales Market Share by Application (2021-2026)
Figure 61. China Non-invasive Vagus Nerve Stimulator Revenue Growth 2021-2026 ($ millions)
Figure 62. Japan Non-invasive Vagus Nerve Stimulator Revenue Growth 2021-2026 ($ millions)
Figure 63. South Korea Non-invasive Vagus Nerve Stimulator Revenue Growth 2021-2026 ($ millions)
Figure 64. Southeast Asia Non-invasive Vagus Nerve Stimulator Revenue Growth 2021-2026 ($ millions)
Figure 65. India Non-invasive Vagus Nerve Stimulator Revenue Growth 2021-2026 ($ millions)
Figure 66. Australia Non-invasive Vagus Nerve Stimulator Revenue Growth 2021-2026 ($ millions)
Figure 67. China Taiwan Non-invasive Vagus Nerve Stimulator Revenue Growth 2021-2026 ($ millions)
Figure 68. Europe Non-invasive Vagus Nerve Stimulator Sales Market Share by Country in 2025
Figure 69. Europe Non-invasive Vagus Nerve Stimulator Revenue Market Share by Country (2021-2026)
Figure 70. Europe Non-invasive Vagus Nerve Stimulator Sales Market Share by Technology Route (2021-2026)
Figure 71. Europe Non-invasive Vagus Nerve Stimulator Sales Market Share by Application (2021-2026)
Figure 72. Germany Non-invasive Vagus Nerve Stimulator Revenue Growth 2021-2026 ($ millions)
Figure 73. France Non-invasive Vagus Nerve Stimulator Revenue Growth 2021-2026 ($ millions)
Figure 74. UK Non-invasive Vagus Nerve Stimulator Revenue Growth 2021-2026 ($ millions)
Figure 75. Italy Non-invasive Vagus Nerve Stimulator Revenue Growth 2021-2026 ($ millions)
Figure 76. Russia Non-invasive Vagus Nerve Stimulator Revenue Growth 2021-2026 ($ millions)
Figure 77. Middle East & Africa Non-invasive Vagus Nerve Stimulator Sales Market Share by Country (2021-2026)
Figure 78. Middle East & Africa Non-invasive Vagus Nerve Stimulator Sales Market Share by Technology Route (2021-2026)
Figure 79. Middle East & Africa Non-invasive Vagus Nerve Stimulator Sales Market Share by Application (2021-2026)
Figure 80. Egypt Non-invasive Vagus Nerve Stimulator Revenue Growth 2021-2026 ($ millions)
Figure 81. South Africa Non-invasive Vagus Nerve Stimulator Revenue Growth 2021-2026 ($ millions)
Figure 82. Israel Non-invasive Vagus Nerve Stimulator Revenue Growth 2021-2026 ($ millions)
Figure 83. Turkey Non-invasive Vagus Nerve Stimulator Revenue Growth 2021-2026 ($ millions)
Figure 84. GCC Countries Non-invasive Vagus Nerve Stimulator Revenue Growth 2021-2026 ($ millions)
Figure 85. Manufacturing Cost Structure Analysis of Non-invasive Vagus Nerve Stimulator in 2026
Figure 86. Manufacturing Process Analysis of Non-invasive Vagus Nerve Stimulator
Figure 87. Industry Chain Structure of Non-invasive Vagus Nerve Stimulator
Figure 88. Channels of Distribution
Figure 89. Global Non-invasive Vagus Nerve Stimulator Sales Market Forecast by Region (2027-2032)
Figure 90. Global Non-invasive Vagus Nerve Stimulator Revenue Market Share Forecast by Region (2027-2032)
Figure 91. Global Non-invasive Vagus Nerve Stimulator Sales Market Share Forecast by Technology Route (2027-2032)
Figure 92. Global Non-invasive Vagus Nerve Stimulator Revenue Market Share Forecast by Technology Route (2027-2032)
Figure 93. Global Non-invasive Vagus Nerve Stimulator Sales Market Share Forecast by Application (2027-2032)
Figure 94. Global Non-invasive Vagus Nerve Stimulator Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Non-invasive Vagus Nerve Stimulator
Figure 2. Non-invasive Vagus Nerve Stimulator Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Non-invasive Vagus Nerve Stimulator Sales Growth Rate 2021-2032 (Units)
Figure 7. Global Non-invasive Vagus Nerve Stimulator Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Non-invasive Vagus Nerve Stimulator Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Non-invasive Vagus Nerve Stimulator Sales Market Share by Country/Region (2025)
Figure 10. Non-invasive Vagus Nerve Stimulator Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Transcutaneous Cervical Vagus Nerve Stimulation (tcVNS)
Figure 12. Product Picture of Transcutaneous Auricular Vagus Nerve Stimulation (taVNS)
Figure 13. Product Picture of Others
Figure 14. Global Non-invasive Vagus Nerve Stimulator Sales Market Share by Technology Route in 2026
Figure 15. Global Non-invasive Vagus Nerve Stimulator Revenue Market Share by Technology Route (2021-2026)
Figure 16. Product Picture of Portable Handheld Devices
Figure 17. Product Picture of Wearable Devices
Figure 18. Product Picture of Others
Figure 19. Global Non-invasive Vagus Nerve Stimulator Sales Market Share by Product Form in 2026
Figure 20. Global Non-invasive Vagus Nerve Stimulator Revenue Market Share by Product Form (2021-2026)
Figure 21. Non-invasive Vagus Nerve Stimulator Consumed in Neurological Disorders
Figure 22. Global Non-invasive Vagus Nerve Stimulator Market: Neurological Disorders (2021-2026) & (Units)
Figure 23. Non-invasive Vagus Nerve Stimulator Consumed in Mental Health Disorders
Figure 24. Global Non-invasive Vagus Nerve Stimulator Market: Mental Health Disorders (2021-2026) & (Units)
Figure 25. Non-invasive Vagus Nerve Stimulator Consumed in Pain Management
Figure 26. Global Non-invasive Vagus Nerve Stimulator Market: Pain Management (2021-2026) & (Units)
Figure 27. Non-invasive Vagus Nerve Stimulator Consumed in Sleep Disorders
Figure 28. Global Non-invasive Vagus Nerve Stimulator Market: Sleep Disorders (2021-2026) & (Units)
Figure 29. Non-invasive Vagus Nerve Stimulator Consumed in Inflammation and Autonomic Regulation
Figure 30. Global Non-invasive Vagus Nerve Stimulator Market: Inflammation and Autonomic Regulation (2021-2026) & (Units)
Figure 31. Non-invasive Vagus Nerve Stimulator Consumed in Others
Figure 32. Global Non-invasive Vagus Nerve Stimulator Market: Others (2021-2026) & (Units)
Figure 33. Global Non-invasive Vagus Nerve Stimulator Sale Market Share by Application (2025)
Figure 34. Global Non-invasive Vagus Nerve Stimulator Revenue Market Share by Application in 2025
Figure 35. Non-invasive Vagus Nerve Stimulator Sales by Company in 2025 (Units)
Figure 36. Global Non-invasive Vagus Nerve Stimulator Sales Market Share by Company in 2025
Figure 37. Non-invasive Vagus Nerve Stimulator Revenue by Company in 2025 ($ millions)
Figure 38. Global Non-invasive Vagus Nerve Stimulator Revenue Market Share by Company in 2025
Figure 39. Global Non-invasive Vagus Nerve Stimulator Sales Market Share by Geographic Region (2021-2026)
Figure 40. Global Non-invasive Vagus Nerve Stimulator Revenue Market Share by Geographic Region in 2025
Figure 41. Americas Non-invasive Vagus Nerve Stimulator Sales 2021-2026 (Units)
Figure 42. Americas Non-invasive Vagus Nerve Stimulator Revenue 2021-2026 ($ millions)
Figure 43. APAC Non-invasive Vagus Nerve Stimulator Sales 2021-2026 (Units)
Figure 44. APAC Non-invasive Vagus Nerve Stimulator Revenue 2021-2026 ($ millions)
Figure 45. Europe Non-invasive Vagus Nerve Stimulator Sales 2021-2026 (Units)
Figure 46. Europe Non-invasive Vagus Nerve Stimulator Revenue 2021-2026 ($ millions)
Figure 47. Middle East & Africa Non-invasive Vagus Nerve Stimulator Sales 2021-2026 (Units)
Figure 48. Middle East & Africa Non-invasive Vagus Nerve Stimulator Revenue 2021-2026 ($ millions)
Figure 49. Americas Non-invasive Vagus Nerve Stimulator Sales Market Share by Country in 2025
Figure 50. Americas Non-invasive Vagus Nerve Stimulator Revenue Market Share by Country (2021-2026)
Figure 51. Americas Non-invasive Vagus Nerve Stimulator Sales Market Share by Technology Route (2021-2026)
Figure 52. Americas Non-invasive Vagus Nerve Stimulator Sales Market Share by Application (2021-2026)
Figure 53. United States Non-invasive Vagus Nerve Stimulator Revenue Growth 2021-2026 ($ millions)
Figure 54. Canada Non-invasive Vagus Nerve Stimulator Revenue Growth 2021-2026 ($ millions)
Figure 55. Mexico Non-invasive Vagus Nerve Stimulator Revenue Growth 2021-2026 ($ millions)
Figure 56. Brazil Non-invasive Vagus Nerve Stimulator Revenue Growth 2021-2026 ($ millions)
Figure 57. APAC Non-invasive Vagus Nerve Stimulator Sales Market Share by Region in 2025
Figure 58. APAC Non-invasive Vagus Nerve Stimulator Revenue Market Share by Region (2021-2026)
Figure 59. APAC Non-invasive Vagus Nerve Stimulator Sales Market Share by Technology Route (2021-2026)
Figure 60. APAC Non-invasive Vagus Nerve Stimulator Sales Market Share by Application (2021-2026)
Figure 61. China Non-invasive Vagus Nerve Stimulator Revenue Growth 2021-2026 ($ millions)
Figure 62. Japan Non-invasive Vagus Nerve Stimulator Revenue Growth 2021-2026 ($ millions)
Figure 63. South Korea Non-invasive Vagus Nerve Stimulator Revenue Growth 2021-2026 ($ millions)
Figure 64. Southeast Asia Non-invasive Vagus Nerve Stimulator Revenue Growth 2021-2026 ($ millions)
Figure 65. India Non-invasive Vagus Nerve Stimulator Revenue Growth 2021-2026 ($ millions)
Figure 66. Australia Non-invasive Vagus Nerve Stimulator Revenue Growth 2021-2026 ($ millions)
Figure 67. China Taiwan Non-invasive Vagus Nerve Stimulator Revenue Growth 2021-2026 ($ millions)
Figure 68. Europe Non-invasive Vagus Nerve Stimulator Sales Market Share by Country in 2025
Figure 69. Europe Non-invasive Vagus Nerve Stimulator Revenue Market Share by Country (2021-2026)
Figure 70. Europe Non-invasive Vagus Nerve Stimulator Sales Market Share by Technology Route (2021-2026)
Figure 71. Europe Non-invasive Vagus Nerve Stimulator Sales Market Share by Application (2021-2026)
Figure 72. Germany Non-invasive Vagus Nerve Stimulator Revenue Growth 2021-2026 ($ millions)
Figure 73. France Non-invasive Vagus Nerve Stimulator Revenue Growth 2021-2026 ($ millions)
Figure 74. UK Non-invasive Vagus Nerve Stimulator Revenue Growth 2021-2026 ($ millions)
Figure 75. Italy Non-invasive Vagus Nerve Stimulator Revenue Growth 2021-2026 ($ millions)
Figure 76. Russia Non-invasive Vagus Nerve Stimulator Revenue Growth 2021-2026 ($ millions)
Figure 77. Middle East & Africa Non-invasive Vagus Nerve Stimulator Sales Market Share by Country (2021-2026)
Figure 78. Middle East & Africa Non-invasive Vagus Nerve Stimulator Sales Market Share by Technology Route (2021-2026)
Figure 79. Middle East & Africa Non-invasive Vagus Nerve Stimulator Sales Market Share by Application (2021-2026)
Figure 80. Egypt Non-invasive Vagus Nerve Stimulator Revenue Growth 2021-2026 ($ millions)
Figure 81. South Africa Non-invasive Vagus Nerve Stimulator Revenue Growth 2021-2026 ($ millions)
Figure 82. Israel Non-invasive Vagus Nerve Stimulator Revenue Growth 2021-2026 ($ millions)
Figure 83. Turkey Non-invasive Vagus Nerve Stimulator Revenue Growth 2021-2026 ($ millions)
Figure 84. GCC Countries Non-invasive Vagus Nerve Stimulator Revenue Growth 2021-2026 ($ millions)
Figure 85. Manufacturing Cost Structure Analysis of Non-invasive Vagus Nerve Stimulator in 2026
Figure 86. Manufacturing Process Analysis of Non-invasive Vagus Nerve Stimulator
Figure 87. Industry Chain Structure of Non-invasive Vagus Nerve Stimulator
Figure 88. Channels of Distribution
Figure 89. Global Non-invasive Vagus Nerve Stimulator Sales Market Forecast by Region (2027-2032)
Figure 90. Global Non-invasive Vagus Nerve Stimulator Revenue Market Share Forecast by Region (2027-2032)
Figure 91. Global Non-invasive Vagus Nerve Stimulator Sales Market Share Forecast by Technology Route (2027-2032)
Figure 92. Global Non-invasive Vagus Nerve Stimulator Revenue Market Share Forecast by Technology Route (2027-2032)
Figure 93. Global Non-invasive Vagus Nerve Stimulator Sales Market Share Forecast by Application (2027-2032)
Figure 94. Global Non-invasive Vagus Nerve Stimulator Revenue Market Share Forecast by Application (2027-2032)
